Pulmicort is a synthetic inhaled corticosteroid used to manage chronic inflammatory airway diseases. Its pharmacological action involves binding to glucocorticoid receptors in lung tissue leading to reduced transcription of genes that encode inflammatory cytokines. This interaction suppresses the production of eicosanoids and adhesion molecules thereby dampening cellular inflammation in the airways. Therapeutically it reduces bronchial hyperreactivity mucus secretion and airway edema improving respiratory symptoms over time. The drug's effect is achieved because it penetrates the airway epithelium and remains active locally while exerting minimal systemic exposure. Consequently the medication provides sustained control of inflammation without the need for frequent dosing adjustments.

Pulmicort is an inhaled corticosteroid medication used to control asthma symptoms. It works by delivering the drug directly to the lungs where it reduces airway inflammation. The active ingredient budesonide binds to corticosteroid receptors in lung cells to suppress inflammatory gene expression. This action decreases the release of cytokines and other mediators that cause swelling and mucus production. By lowering inflammation the medication improves breathing and reduces the frequency of asthma attacks. Budesonide is lipophilic and penetrates the airway epithelium to reach immune cells selectively. Its controlled release provides sustained anti-inflammatory effects while minimizing systemic exposure. Overall Pulmicort modulates the immune response in the respiratory tract to maintain airway patency.

The most common side effects reported in clinical studies include headache, dizziness, nausea, fatigue, fever, muscle aches, and cough. These reactions are generally mild to moderate and often resolve without intervention. Headache occurs frequently and may affect concentration in some individuals. Dizziness can manifest as light-headedness or unsteadiness, particularly after dosing. Nausea typically presents as a feeling of stomach discomfort and may accompany loss of appetite. Fatigue is characterized by a sense of tiredness that can persist for several days after treatment. Fever, muscle aches, and cough are less frequent but have been documented as part of the expected side-effect profile.

The most common side effects of vaccination are usually mild and short lived. Headache is frequently reported by many recipients. Fatigue often follows the injection. Nausea can also occur in some individuals. Dizziness is another commonly observed symptom. Dry mouth is reported by a modest number of people. Muscle aches are frequently listed among side effects. Fever and chills are noted but tend to resolve quickly.